ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

Teva Branded Pharmaceutical Products R&D, Inc. · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
adolescents
tourette syndrome, adolescents, children, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811342
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.